KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Share-based Compensation (2016 - 2026)

Edwards Lifesciences has reported Share-based Compensation over the past 17 years, most recently at $39.2 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 23.66% year-over-year to $39.2 million; the TTM value through Dec 2025 reached $158.1 million, down 2.59%, while the annual FY2025 figure was $158.1 million, 2.59% down from the prior year.
  • Share-based Compensation for Q4 2025 was $39.2 million at Edwards Lifesciences, down from $41.2 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $44.6 million in Q1 2024 and troughed at $24.2 million in Q4 2021.
  • A 5-year average of $34.8 million and a median of $34.4 million in 2022 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: rose 29.14% in 2024 and later dropped 14.58% in 2025.
  • Year by year, Share-based Compensation stood at $24.2 million in 2021, then grew by 15.29% to $27.9 million in 2022, then increased by 9.32% to $30.5 million in 2023, then increased by 3.93% to $31.7 million in 2024, then grew by 23.66% to $39.2 million in 2025.
  • Business Quant data shows Share-based Compensation for EW at $39.2 million in Q4 2025, $41.2 million in Q3 2025, and $37.5 million in Q2 2025.